NCT00092703View on ClinicalTrials.gov

Investigational Drug Versus an Approved Drug in Patients With Osteoarthritis (0663-061)(COMPLETED)

PHASE3CompletedINTERVENTIONAL
Enrollment

6,000

Participants

Timeline

Start Date

June 27, 2002

Primary Completion Date

November 1, 2003

Study Completion Date

November 1, 2003

Conditions
Osteoarthritis
Interventions
DRUG

MK0663, etoricoxib

DRUG

Comparator: Diclofenac sodium

All Listed Sponsors
lead

Organon and Co

INDUSTRY

NCT00092703 - Investigational Drug Versus an Approved Drug in Patients With Osteoarthritis (0663-061)(COMPLETED) | Biotech Hunter | Biotech Hunter